Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Neos Therapeutics, Inc. (NASDAQ: NEOS).

Full DD Report for NEOS

You must become a subscriber to view this report.


Recent News from (NASDAQ: NEOS)

Neos Therapeutics Announces Realignment of Commercial Organization
– Strategic assessment leads to new salesforce structure and is expected to accelerate path to profitability –   – Company to host conference call today at 8:30am ET – DALLAS and FORT WORTH, Texas, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Neos Therapeut...
Source: GlobeNewswire
Date: November, 30 2018 07:30
Neos Therapeutics Announces Pricing of Underwritten Public Offering of $40 Million of Common Stock
DALLAS and FORT WORTH, Texas, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a fully-integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative modified-release products using its proprietary microparticle, drug delivery t...
Source: GlobeNewswire
Date: November, 06 2018 09:21
Earnings movers top premarket losers list
OncoSec Medical (NASDAQ: ONCS )  -58%  on mid-stage TAVO data . More news on: OncoSec Medical Incorporated, frontdoor, inc., AAC Holdings, Inc., Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 09:17
After hours: ELF leads gainers, losers include NBIX and THC
More news on: e.l.f. Beauty, Commercial Vehicle Group, Inc., Fabrinet, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: November, 05 2018 17:40
Neos Thera down 11.6% on capital raise
The company is offering an undisclosed amount of shares, with underwriter greenshoe for another 15% of the number of shares sold. More news on: Neos Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: November, 05 2018 17:12
Neos Therapeutics Announces Proposed Offering of Common Stock
DALLAS and FORT WORTH, Texas, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a fully-integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative modified-release products using its proprietary microparticle, drug delivery t...
Source: GlobeNewswire
Date: November, 05 2018 16:03
Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018
DALLAS and FORT WORTH, Texas, , Nov. 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will report third quarter 2018 financial results prior to the opening of U.S. financial markets on Friday, November 9, 2018. Neos management will host a conferenc...
Source: GlobeNewswire
Date: November, 02 2018 07:30
Neos Therapeutics to Present New Data for ADHD Medication, Adzenys XR-ODT®, at the American Academy of Child & Adolescent Psychiatry Meeting
DALLAS and FORT WORTH, Texas, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will present new data for Adzenys XR-ODT (amphetamine) Extended-Release Orally-Disintegrating Tablets, at the 65 th Annual Meeting of the American Academy of Child...
Source: GlobeNewswire
Date: October, 24 2018 08:00
Neos Therapeutics in-licenses excessive salivation candidate from NeuRx Pharma; shares up 2%
Neos Therapeutics ( NEOS +2.1% ) inks a license agreement with NeuRx Pharmaceuticals, LLC for the rights to NRX 101, an active metabolite of oxybutynin, an anticholinergic drug used to treat urinary incontinence and overactive bladder, for the treatment of sialorrhea (excessive salivatio...
Source: SeekingAlpha
Date: October, 23 2018 12:32
Neos Therapeutics Licenses Pipeline Candidate for Treatment of Sialorrhea (Excessive Drooling)
Approximately 1.4 Million Patients in the U.S. with Neurological Diseases Battle Sialorrhea with Burdensome and Complex Treatment Options Development Strategy Leverages Neos’ Modified-Release Microparticle, Drug Delivery Technology and R&D Expertise DALLAS and FORT WORTH...
Source: GlobeNewswire
Date: October, 23 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-194.954.905.004.90109,049
2018-09-185.004.955.104.85187,571
2018-09-175.205.105.254.955164,144
2018-09-145.455.205.455.10205,414
2018-09-135.505.405.705.3591,705

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1331,42196,93932.4132Cover
2018-12-1222,810104,41821.8449Cover
2018-12-1158,081272,27921.3314Cover
2018-12-1014,58076,47619.0648Cover
2018-12-0734,926110,21431.6893Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NEOS.


About Neos Therapeutics, Inc. (NASDAQ: NEOS)

Logo for Neos Therapeutics, Inc. (NASDAQ: NEOS)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $213,127,627 - 05/11/2018
  • Issue and Outstanding: 28,996,956 - 11/03/2017

 


Recent Filings from (NASDAQ: NEOS)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 09 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: May, 02 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 16 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 15 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: NEOS)

Daily Technical Chart for (NASDAQ: NEOS)


Stay tuned for daily updates and more on (NASDAQ: NEOS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NEOS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NEOS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NEOS and does not buy, sell, or trade any shares of NEOS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/